Glemanserin

CAS No. 107703-78-6

Glemanserin( —— )

Catalog No. M33884 CAS No. 107703-78-6

Glemanserin (MDL11939) is a specific 5-HT2A antagonist with Ki values of 0.54 nM, 2.5 nM and 2.89 nM for rabbit, human and rat 5-HT2A.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 52 Get Quote
5MG 76 Get Quote
10MG 122 Get Quote
25MG 264 Get Quote
50MG 419 Get Quote
100MG 605 Get Quote
500MG 1287 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Glemanserin
  • Note
    Research use only, not for human use.
  • Brief Description
    Glemanserin (MDL11939) is a specific 5-HT2A antagonist with Ki values of 0.54 nM, 2.5 nM and 2.89 nM for rabbit, human and rat 5-HT2A.
  • Description
    Glemanserin (MDL11939) is a potent and selective antagonist for serotonin receptor 5-HT2A (Ki=2.89, 0.54 and 2.5 nM for rat 5-HT2A, rabbit 5-HT2A and human 5-HT2A, respectively).
  • In Vitro
    ——
  • In Vivo
    Glemanserin (MDL11939) suppressesthe induced increase in locomotor activity, behavioral sensitization and withdrawal symptoms in male mice.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    107703-78-6
  • Formula Weight
    295.42
  • Molecular Formula
    C20H25NO
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (338.50 mM; Ultrasonic )
  • SMILES
    OC(C1CCN(CCc2ccccc2)CC1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pehek EA, et al. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology. 2006;31(2):265-277. ?
molnova catalog
related products
  • Nelotanserin

    A potent, selective 5-HT2A inverse agonist with pKi of 9.2; displays >30- and 5000-fold selectivity compared with 5-HT2C and 5-HT2B receptors.

  • DSP-1053

    DSP-1053 is a novel potent serotonin reuptake (SERT) inhibitor with 5-HT1A partial agonistic activity that binds to human serotonin transporter and 5-HT1A receptor with Ki of 1.02 and 5.05 nM, respectively.

  • Didesmethyl caripraz...

    Didesmethyl cariprazine, a metabolite of Cariprazine, is the major cyclic active part. Didesmethyl cariprazine has a long half-life of 1-3 weeks.